JP2022500485A5 - - Google Patents
Info
- Publication number
- JP2022500485A5 JP2022500485A5 JP2021517311A JP2021517311A JP2022500485A5 JP 2022500485 A5 JP2022500485 A5 JP 2022500485A5 JP 2021517311 A JP2021517311 A JP 2021517311A JP 2021517311 A JP2021517311 A JP 2021517311A JP 2022500485 A5 JP2022500485 A5 JP 2022500485A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- hours
- dosage form
- unit dosage
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862737285P | 2018-09-27 | 2018-09-27 | |
| US62/737,285 | 2018-09-27 | ||
| US201962834513P | 2019-04-16 | 2019-04-16 | |
| US62/834,513 | 2019-04-16 | ||
| PCT/US2019/053413 WO2020069288A1 (en) | 2018-09-27 | 2019-09-27 | Grapiprant unit dosage forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022500485A JP2022500485A (ja) | 2022-01-04 |
| JP2022500485A5 true JP2022500485A5 (cg-RX-API-DMAC7.html) | 2022-10-05 |
Family
ID=69953354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517311A Pending JP2022500485A (ja) | 2018-09-27 | 2019-09-27 | グラピプラント単位剤形 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210353648A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3856177A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022500485A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113260363A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3113468A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020069288A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112292128A (zh) | 2018-04-16 | 2021-01-29 | 阿瑞斯医疗有限公司 | Ep4抑制剂和其用途 |
| US20210315909A1 (en) | 2018-07-11 | 2021-10-14 | Arrys Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| WO2021205367A1 (en) * | 2020-04-08 | 2021-10-14 | Askat Inc. | Use of ep4 receptor antagonists for the treatment of liver cancer, melanoma, lymphoma and leukemia |
| CN115919756B (zh) * | 2022-10-19 | 2024-08-23 | 梅州市珍宝金柚实业有限公司 | 一种金柚原浆口服液及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602007011792D1 (de) * | 2006-10-27 | 2011-02-17 | Fmc Corp | Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen |
| CA2754702C (en) * | 2009-04-22 | 2016-06-07 | Yukinori Take | Selective ep4 antagonistic substance for treatment of cancer |
| JP2014520865A (ja) * | 2011-07-15 | 2014-08-25 | ユーファーマ プロプライエタリー リミテッド | 制酸剤、麻酔薬、ならびに二酸化ケイ素と二酸化チタンとを含んでなる無機マトリックスを含んでなる経口用組成物 |
| CA2918277C (en) * | 2013-07-16 | 2021-02-16 | Cadila Pharmaceuticals Limited | Indole-3-carbinol derivatives |
| TWI664969B (zh) * | 2014-03-06 | 2019-07-11 | 雅瑞塔那醫療公司 | 格拉匹綸(grapiprant)組合物及其使用方法 |
-
2019
- 2019-09-27 CA CA3113468A patent/CA3113468A1/en active Pending
- 2019-09-27 CN CN201980072471.4A patent/CN113260363A/zh active Pending
- 2019-09-27 JP JP2021517311A patent/JP2022500485A/ja active Pending
- 2019-09-27 EP EP19865430.3A patent/EP3856177A4/en not_active Withdrawn
- 2019-09-27 WO PCT/US2019/053413 patent/WO2020069288A1/en not_active Ceased
- 2019-09-27 US US17/278,601 patent/US20210353648A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018510178A5 (cg-RX-API-DMAC7.html) | ||
| CA2568443A1 (en) | Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihistamines | |
| JP7754799B2 (ja) | てんかん重積状態の治療に使用するためのガナキソロン | |
| WO2008122190A1 (en) | The composition comprising l-carnitine or derivatives thereof and its use | |
| JP2023552700A5 (cg-RX-API-DMAC7.html) | ||
| JP2010065060A (ja) | 心不全処置のための複合治療 | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| CN110123771A (zh) | 药物组合药物 | |
| JP2005528429A (ja) | 活性成分の徐放性を有するオクスカルバゼピン含有薬学的組成物 | |
| JP6509729B2 (ja) | 慢性腎臓病の進行抑制又は改善剤 | |
| JP2022525202A (ja) | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と1日あたりの投薬量 | |
| JP2023139157A (ja) | 抗線維化療法を投与する方法 | |
| AU2023397768A1 (en) | Stat3 inhibitors for use in the treatment of non-viral liver cancer | |
| BRPI0717052A2 (pt) | Tratamento de doença reumatoide com glucocorticoide de liberação retardada | |
| JP2004091473A (ja) | 色素沈着改善治療薬 | |
| JP2022177119A5 (cg-RX-API-DMAC7.html) | ||
| WO2012071535A2 (en) | Pediatric formulation | |
| JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および/または症状軽減剤 | |
| AU2011339150A1 (en) | Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof | |
| CN112912070A (zh) | 夜间多尿的治疗或预防剂 | |
| WO2019004465A1 (ja) | ペマフィブラートを含有する医薬 | |
| JP2016514125A (ja) | バルサルタン及びロスバスタチンカルシウムを含む複合製剤及びその製造方法 | |
| JP6420923B1 (ja) | 医薬 | |
| CN115315258A (zh) | 肾功能保护剂 | |
| TWI744858B (zh) | 治療精神疾病之控釋藥物組合物和方法 |